Compounds > phosphoserine

phosphoserine and tamoxifen

phosphoserine has been researched along with tamoxifen in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Marignani, PA; Scheid, MP; Woodgett, JR1
Ali, S; Coombes, RC; Gee, JM; Jiang, J; Kim, JS; Lykkesfeldt, AE; Madden, P; Nicholson, RI; Peston, D; Sarwar, N; Shousha, S; Sinnett, HD1
Dougherty, SM; Ivanova, MM; Klinge, CM; Mazhawidza, W1
Baidas, S; Baker, CH; Bobustuc, GC; Caparas, ML; Constantino, SM; Isley, B; Jeudy, S; Konduri, SD; Limaye, A; Maddipatla, S; Shah, N; Smith, JS; Srivenugopal, KS1
Bian, XW; Cao, Y; Ge, X; Guan, K; He, X; Hu, C; Li, J; Ling, Y; Ma, S; Song, T; Tai, Y; Wang, Q; Wei, C; Xu, C; Xu, Q; Yan, H; Yang, X; Zhang, B; Zhang, Y; Zheng, Z; Zhong, H; Zhu, L1
Alonso, DF; Cardama, GA; Comin, MJ; Gomez, DE; Gonzalez, N; Menna, PL; Pifano, M; Segatori, VI1

Other Studies

6 other study(ies) available for phosphoserine and tamoxifen

ArticleYear
Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B.
    Molecular and cellular biology, 2002, Volume: 22, Issue:17

    Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Binding Sites; Cattle; Cell Line; Cell Membrane; Dimerization; Enzyme Activation; Enzyme Inhibitors; Humans; Insulin-Like Growth Factor I; Kidney; Membrane Proteins; Phosphatidylinositol 3-Kinases; Phosphorylation; Phosphoserine; Phosphothreonine; Protein Interaction Mapping; Protein Kinases; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Estrogen; Recombinant Fusion Proteins; Sirolimus; Tacrolimus Binding Protein 1A; Tamoxifen; TOR Serine-Threonine Kinases; Transfection

2002
Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progression.
    Endocrine-related cancer, 2006, Volume: 13, Issue:3

    Topics: Biomarkers, Tumor; Breast Neoplasms; Disease Progression; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Humans; Immunohistochemistry; Phosphorylation; Phosphoserine; Prognosis; Tamoxifen; Tumor Cells, Cultured

2006
Sex differences in estrogen receptor subcellular location and activity in lung adenocarcinoma cells.
    American journal of respiratory cell and molecular biology, 2010, Volume: 42, Issue:3

    Topics: Adenocarcinoma; Cell Line, Tumor; Cell Nucleus; Cyclin D1; Enzyme Activation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Female; Fluorescence; Fulvestrant; Genome, Human; Humans; Lung Neoplasms; Male; Microscopy, Confocal; Mitogen-Activated Protein Kinases; Mutant Proteins; Phosphoserine; Protein Transport; Sex Characteristics; Signal Transduction; Subcellular Fractions; Tamoxifen

2010
MGMT inhibition restores ERĪ± functional sensitivity to antiestrogen therapy.
    Molecular medicine (Cambridge, Mass.), 2012, Sep-07, Volume: 18

    Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; DNA Modification Methylases; DNA Repair Enzymes; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estrogen Antagonists; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Guanine; Humans; Immunohistochemistry; Mice; Mice, Nude; Phosphorylation; Phosphoserine; Promoter Regions, Genetic; Protein Binding; Tamoxifen; Transcription, Genetic; Tumor Suppressor Protein p53; Tumor Suppressor Proteins

2012
Elevated expression of TANK-binding kinase 1 enhances tamoxifen resistance in breast cancer.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Feb-04, Volume: 111, Issue:5

    Topics: Breast Neoplasms; Cell Line, Tumor; Cyclin D1; Drug Resistance, Neoplasm; Estrogen Receptor alpha; Female; Humans; Immunity, Innate; Kaplan-Meier Estimate; Phosphorylation; Phosphoserine; Protein Binding; Protein Serine-Threonine Kinases; Tamoxifen; Transcription, Genetic; Treatment Outcome

2014
Pharmacological inhibition of Rac1-PAK1 axis restores tamoxifen sensitivity in human resistant breast cancer cells.
    Cellular signalling, 2017, Volume: 30

    Topics: Breast Neoplasms; Drug Resistance, Neoplasm; Estrogens; Female; Humans; MCF-7 Cells; Models, Biological; p21-Activated Kinases; Phenotype; Phosphorylation; Phosphoserine; Protein Kinase Inhibitors; rac1 GTP-Binding Protein; Signal Transduction; Tamoxifen; Up-Regulation

2017